Poster (Scientific congresses and symposiums)
The mTor inhibitor rapamycin delays xenogeneic acute graft versus host disease (aGVHD) in NOD/SCID/IL2rgnull mice (NSG): impact of regulatory T cells
Bruck, France; BARON, Frédéric; Dubois, Sophie et al.
2011Belgian Hematological Society Annual General Meeting
 

Files


Full Text
Bruck-P-BHS2011.pdf
Publisher postprint (38.52 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Hematology
Author, co-author :
Bruck, France
BARON, Frédéric  ;  Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Dubois, Sophie
BRIQUET, Alexandra ;  Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie
Hannon, Muriel ;  Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie
Belle, Ludovic ;  Université de Liège - ULiège > GIGA-R : Hématologie
MENTEN, Catherine ;  Centre Hospitalier Universitaire de Liège - CHU > Centre d'oncologie
BEGUIN, Yves  ;  Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Humblet-Baron, Stéphanie
Language :
English
Title :
The mTor inhibitor rapamycin delays xenogeneic acute graft versus host disease (aGVHD) in NOD/SCID/IL2rgnull mice (NSG): impact of regulatory T cells
Publication date :
2011
Event name :
Belgian Hematological Society Annual General Meeting
Event date :
Janvier 2011
Audience :
International
Available on ORBi :
since 22 May 2013

Statistics


Number of views
38 (5 by ULiège)
Number of downloads
53 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi